Advertisement
News
Advertisement

Frost & Sullivan Chooses Xenex for New Product Innovation Award in Hospital & Safety Prevention Technologies

Mon, 11/12/2012 - 9:24am
The Associated Press

SAN ANTONIO--(BUSINESS WIRE)--Nov 12, 2012--Xenex Healthcare Services, the world leader in UV room disinfection systems, today announced it has been awarded Frost & Sullivan’s 2012 U.S. New Product Innovation Award in Hospital and Safety Prevention Technologies. A “green,” mercury-free technology, Xenex offers the fastest, safest, and most cost-effective method for the automated disinfection of healthcare facilities.

"Xenex is being recognized with the Frost & Sullivan 2012 New Product Innovation Award in Hospital Safety and Prevention Technologies because more than any other available technology, the Xenex system is able to provide superior effectiveness in disinfection along with functionality that is easy to learn and operate," said Venkat Rajan, Industry Manger, Frost & Sullivan. "Hospitals that have implemented use of the Xenex system have documented immediate reduction in the presence of drug-resistant microorganisms. Beyond the clinical benefit, facilities have noticed an immediate return on investment through various patient care and operational cost savings. The innovative elements of Xenex's cutting-edge room disinfection system make it stand out from other technologies and systems and we are proud to present them with this well-deserved award." Healthcare associated infections (also referred to as HAIs) are the fourth leading cause of death in the United States, costing more than $30 billion each year. Evidence continues to mount that the hospital environment plays a critical role in the spread of HAIs, which are caused by deadly pathogens such as C. diff, MRSA, VRE and Acinetobacter. Hospital cleaning teams are not able to disinfect all the surfaces in patient rooms, with research showing that more than half of the surfaces remain untouched. Additionally, deadly “superbugs” are showing resistance to cleaning chemicals, making the pathogens even more difficult to remove and eliminate.

Xenex’s portable room disinfection system uses pulsed xenon ultraviolet light to destroy viruses, bacteria and bacterial spores in the patient environment without contact or chemicals. Uniquely designed for ease of use and portability, a hospital’s environmental services staff can operate the Xenex device without disrupting hospital operations or requiring the use of expensive chemicals. The Xenex system will disinfect over thirty (30) rooms per day, so hospitals use the system continuously to reduce contamination levels throughout their facilities.

“We have proven repeatedly that the science of our pulsed xenon light makes it incredibly effective against the most challenging bacteria, viruses and even C. diff spores,” said Mark Stibich, Chief Scientific Officer of Xenex. “Xenex customer Cooley Dickinson Hospital just presented a study which showed they had a 53 percent reduction in hospital acquired C. diff when the Xenex device was used to disinfect patient rooms at discharge, operating rooms, emergency rooms, and other areas as available. In another recent study, Cone Health reported that their MRSA rates dropped 56 percent in 2011 after they implemented an infection prevention program including Xenex’s device.” “Xenex’s mission is to save lives and reduce suffering by preventing healthcare associated infections. Hospitals using our room disinfection devices are experiencing fewer infections and are able to provide a safer environment for their patients, staff and visitors,” said Morris Miller, CEO of Xenex. “We applaud Frost & Sullivan for acknowledging that HAIs are a national health crisis and presenting their findings, after conducting exhaustive research, that our device is superior to other technologies for helping hospitals combat this problem.” Xenex devices are made in the U.S. and friendlier to the environment than current housecleaning chemicals or other UV devices using toxic mercury. Xenex is the only company to offer a xenon-based room disinfection product that is patented, tested, and proven to deliver a germicidal dose of UV-C light capable of killing C. diff in five minutes or less. Xenex systems, currently in use by hospitals throughout the U.S., have proven to be effective against a variety of the most dangerous superbugs, including Clostridium difficile endospores (C. diff), MRSA, VRE, and Acinetobacter. Studies show the Xenex room disinfection system is consistently 20 times more effective than standard chemical cleaning practices and a recent study performed at MD Anderson Cancer Center demonstrated that the Xenex system was more effective than bleach in reducing C. diff. in patient rooms.

About Xenex Healthcare Services Xenex’s patented pulsed xenon UV disinfection systems are utilized for the advanced cleaning of the patient environment in healthcare facilities. The Xenex system is the fastest, safest, most cost-effective, and most portable and user-friendly system available today among room disinfection technologies. Only Xenex uses pulsed xenon and contains no mercury. The Xenex mission is to significantly reduce the number of HAIs that impact the health and lives of millions of patients and their families and become the new standard method for disinfection in healthcare facilities worldwide. For more information please visit http://www.xenex.com.

CONTACT: Xenex Healthcare Services Melinda Hart, 210-824-3433 melinda.hart@xenex.com KEYWORD: UNITED STATES NORTH AMERICA TEXAS INDUSTRY KEYWORD: PRACTICE MANAGEMENT HEALTH HOSPITALS MEDICAL DEVICES MANAGED CARE SOURCE: Xenex Healthcare Services Copyright Business Wire 2012 PUB: 11/12/2012 09:24 AM/DISC: 11/12/2012 09:24 AM http://www.businesswire.com/news/home/20121112005944/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading